Order Article Reprints

Krug D, Tio J, Abaci A, Beurer B, Brügge S, Elsayad K, Meixner E, Park-Simon T-W, Smetanay K, Winkelmann F, et al. The Safety and Efficacy of the Combination of Sacituzumab Govitecan and Palliative Radiotherapy—A Retrospective Multi-Center Cohort Study. Cancers. 2024; 16(9):1649. https://doi.org/10.3390/cancers16091649

Krug, David, Joke Tio, Ali Abaci, Björn Beurer, Sandra Brügge, Khaled Elsayad, Eva Meixner, Tjoung-Won Park-Simon, Katharina Smetanay, Franziska Winkelmann, and et al. 2024. "The Safety and Efficacy of the Combination of Sacituzumab Govitecan and Palliative Radiotherapy—A Retrospective Multi-Center Cohort Study" Cancers 16, no. 9: 1649. https://doi.org/10.3390/cancers16091649

Krug, D., Tio, J., Abaci, A., Beurer, B., Brügge, S., Elsayad, K., Meixner, E., Park-Simon, T.-W., Smetanay, K., Winkelmann, F., Wittig, A., & Wöckel, A. (2024). The Safety and Efficacy of the Combination of Sacituzumab Govitecan and Palliative Radiotherapy—A Retrospective Multi-Center Cohort Study. Cancers, 16(9), 1649. https://doi.org/10.3390/cancers16091649